Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis.
A group of 54 patients with rheumatoid arthritis (31 fast, 23 slow acetylators) treated with sulphasalazine 3 g/day were studied retrospectively. At 24 weeks no difference in the efficacy of the drug could be shown between fast and slow acetylators. In a second prospective study 40 fast acetylators...
Na minha lista:
| Publicado no: | Ann Rheum Dis |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
1985
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1001793/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2867746/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.44.12.831 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|